[Irritable bowel syndrome in the light of Rome consensus III (2006): 10 years later].

Irritable bowel syndrome (IBS) is the most common diagnosis in gastroenterology. Over 10 years after Rome consensus III (2006), there has been much new information on the pathogenesis of IBS and its therapy options. The paper analyzes basic investigations that have contributed to the theory of this disease and to a better quality of life in patients.

[Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up].

Aim: To compare the safety of therapy in patients with ulcerative colitis (UC) and Crohn's disease (CD) who have received combination anti-inflammatory therapy using bone marrow mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicylic acid, glucocorticosteroids, and immunosuppressive agents.

Subjects And Methods: Unfavorable consequences were analyzed in 103 patients (56 with UC and 47 with CD) with inflammatory bowel disease (IBD) after MSC administration. The findings were compared with data obtained in 208 patients with UC and CD on standard anti-inflammatory therapy.

[Cachexia and multiorgan insufficiency in a patient with small intestine carcinoid].

Carcinoid of the thin bowel is difficult to diagnose pathology. Complications diagnosticians with that doctors clash on ambulatory and hospital the stages, including at offtype clinical presentation of disease, result in late recognition of carcinoid and belated operative intervention. In taken apart case a diagnosis was set at pathomorphologic research.

[Violation of bone mineral density tissue and its correction in patients with celiac disease].

There are shown results of studies of bone mineral density in patients with celiac disease. The problem of malabsorption syndrome with clinical and pathogenetic point of view, which can lead to bone loss due to on absorption violations of calcium and vitamin D at celiac disease. Also into account the effect of proinflammatory cytokines and hormones on calcium regulated processes of bone remodeling.

[Bone mineral density in patients with celiac disease and medical treatment of the disorder].

The article presents the results of a bone mineral density study in patients with glutensensitive celiac disease. Was discussed problem of malabsorption syndrome with clinical and pathogenetic point of view, which can lead to bone loss due to malabsorption of calcium and vitamin D for celiac disease. Also was take into account the effect of inflammatory cytokines and hormones on calcium regulating processes of bone remodeling.